Amgen Oncology becomes a Founding Partner

We are delighted to welcome Amgen as a Founding Partner of The Cancer Platform. Amgen is one of the world's largest independent biotechnology companies and is committed advancing all angles of care by delivering a spectrum of cancer treatment options that address wide-ranging patient needs.

Amgen’s support will help get The Cancer Platform live and ensure it connects, complements and catalyses outstanding initiatives addressing gaps, inequities and inequalities in cancer care.

Mike Zatyka, Director of Fundraising says: "We are proud to have Amgen’s support to help The Cancer Platform to empower people affected by cancer with trusted and quick answers and reduce disparities in access to information, services and products."

Jeanette Schulz, Director of Health Equity and Advocacy Relations at Amgen says: “Navigating your cancer journey can be daunting. The Cancer Platform hopes to play a part in making it easier for patients and their families to access trusted information and resources at the right time in their care journey. Amgen is proud to support The Cancer Platform as it begins to build this important resource for the community.”

Sir Chris Evans, Co-Founder of The Cancer Awareness Trust says: “Amgen sets the benchmark for the ambitious type of collaboration we need if we are to realise the full vision of The Cancer Platform around the world. It is hugely exciting to go on this journey with them.”